Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.scr.2008.07.004
DC FieldValue
dc.titleDerivation of functional insulin-producing cell lines from primary mouse embryo culture
dc.contributor.authorLi, G.D.
dc.contributor.authorLuo, R.
dc.contributor.authorZhang, J.
dc.contributor.authorXie, F.
dc.contributor.authorLim, S.K.
dc.contributor.authorSalto-Tellez, M.
dc.contributor.authorYeo, K.S.
dc.contributor.authorWay, Tan E.K.
dc.contributor.authorCaille, D.
dc.contributor.authorMeda, P.
dc.contributor.authorQue, J.
dc.contributor.authorKon, O.L.
dc.date.accessioned2012-01-30T09:44:59Z
dc.date.available2012-01-30T09:44:59Z
dc.date.issued2009
dc.identifier.citationLi, G.D., Luo, R., Zhang, J., Xie, F., Lim, S.K., Salto-Tellez, M., Yeo, K.S., Way, Tan E.K., Caille, D., Meda, P., Que, J., Kon, O.L. (2009). Derivation of functional insulin-producing cell lines from primary mouse embryo culture. Stem Cell Research 2 (1) : 29-40. ScholarBank@NUS Repository. https://doi.org/10.1016/j.scr.2008.07.004
dc.identifier.issn18735061
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/30147
dc.description.abstractWe have previously described the derivation of insulin-producing cell lines from mouse embryonic stem cells (mESCs) by differentiation of an intermediate lineage-restricted E-RoSH cell line through nutrient depletion in the presence of nicotinamide followed by limiting dilution. Here we investigated whether insulin-producing cell lines could be similarly derived directly from mouse embryo cells or tissues. Using a similar approach, we generated the RoSH2.K and MEPI-1 to -14 insulin-producing cell lines from the 5.5-dpc embryo-derived E-RoSH-analogous RoSH2 cell line and a 6.0-dpc mouse embryo culture, respectively. Insulin content was ∼8 μg/106 MEPI-1 cells and 0.5 μg/106 RoSH2.K cells. Like insulin-producing mESC-derived ERoSHK cell lines, both MEPI and RoSH2.K lines were amenable to repeated cycles of freeze and thaw, replicated for months with a doubling time of 3-4 days, and exhibited genomic, structural, biochemical, and pharmacological properties of pancreatic β-cells, including storage and release of insulin and C-peptide in an equimolar ratio. Transplantation of these cells also reversed hyperglycemia in streptozotocin-treated SCID mice and did not induce teratoma. Like ERoSHK cells, both RoSH2.K and MEPI-1 cells also induced hypoglycemia in the mice. Therefore, our protocol is robust and could reproducibly generate insulin-producing cell lines from different embryonic cell sources. © 2008 Elsevier B.V. All rights reserved.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.scr.2008.07.004
dc.sourceScopus
dc.typeArticle
dc.contributor.departmentBIOCHEMISTRY
dc.contributor.departmentSURGERY
dc.contributor.departmentNATIONAL UNIVERSITY MEDICAL INSTITUTES
dc.description.doi10.1016/j.scr.2008.07.004
dc.description.sourcetitleStem Cell Research
dc.description.volume2
dc.description.issue1
dc.description.page29-40
dc.identifier.isiut000269909000005
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

7
checked on Apr 8, 2021

WEB OF SCIENCETM
Citations

7
checked on Apr 8, 2021

Page view(s)

209
checked on Mar 31, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.